Biotech Market Experience

We push our clients in synthetic biology to prioritize high-value, low-volume products. We help pinpoint opportunities where biology outperforms chemistry and share our frameworks for techno-economic analysis to yield high margin product portfolios. Competition and incumbents play a large role here and we ensure our clients develop thorough mental models for dealing with these challenge. 

Our consultancy is well versed in CDMO and reagent product development, providing strategic guidance on market selection and competitive positioning. Leveraging industry insights, market research, and our larger network of experts, Breakthrough Bio can help you uniquely develop your value proposition.

With an eye towards cell free DNA and protein based diagnostics, our team has supported companies overcome regulatory hurdles to launch first in class diagnostic tests. We are also accustomed to broader strategies surrounding healthcare coverage and medical adoption.

Specializing in senescence, genomic instability, and autophagy, our team excels in navigating the intricate dynamics of aging biology. Our insights have generated novel strategies for targeting high value, underserved patient populations while avoiding the pitfalls that have led other companies to ruin. Given the challenges with longevity clinical trials, we help target diseases where aging biology can produce best-in-class and first-in-class therapeutics, from biologics, small molecules, and cell and gene therapy based approaches.